Amgen Inc Stock Performance
as on April 17, 2026 at 6:59 am IST
Day's Low
Day's High
$346.60$351.25
0.79%
Downside
0.54%
Upside
52 Week's Low
52 Week's High
$261.43$391.2925.17%
Downside
12.00%
Upside
Amgen Inc share price movements today
- Previous Close
- $348.22
- Open
- $347.32
- Volume
- 1.3M
- Day's Low - High
- $346.60 - $351.25
- 52 Week Low - High
- $261.43 - $391.29
Amgen Inc Historical Returns
- 1 Month Return
- -3.25 %
- 3 Month Return
- + 5.74 %
- 1 Year Return
- + 26 %
- 3 Year Return
- + 40.84 %
- 5 Year Return
- + 36.64 %
Amgen Inc Stock Fundamentals & Key Indicators
Check Amgen Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$188.3B
EPS (TTM)
22.3491
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
1.12%
PE Ratio (TTM)
24.57
Industry PE ratio
20.783
PEG Ratio
2.333
EBITDA
16.6B
Revenue (TTM)
36.8B
Profit Margin
20.98%
Return On Equity TTM
106.10%
Amgen Inc Stock Valuation
Track how Amgen Inc P/E has moved over time to understand its valuation trends.
Amgen Inc in the last 5 years
Lowest (12.34x)
December 31, 2021
Industry (20.78x)
April 17, 2026
Today (24.57x)
April 17, 2026
Highest (17.02x)
September 30, 2024
Today’s Price to Earnings Ratio: 24.57x
Amgen Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Amgen Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $188.3B | 36.64% | 24.57 | 20.98% | |
| BUY | $- | 296.55% | NA | 0.00% | |
| BUY | $809.1B | 377.67% | 39.32 | 31.67% | |
| BUY | $565.2B | 44.56% | 21.26 | 21.83% | |
| BUY | $368.6B | 93.67% | 87.57 | 6.91% |
Stock Returns calculator for Amgen Inc Stock including INR - Dollar returns
The Amgen Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Amgen Inc investment value today
Current value as on today
₹1,37,285
Returns
₹37,285
(+37.28%)
Returns from Amgen Inc Stock
₹25,991 (+25.99%)
Dollar Impact
₹11,294 (+11.29%)
Analyst Recommendation on Amgen Inc Stock
Based on 37 analysts
56.76%
Buy
35.14%
Hold
8.11%
Sell
Based on 37 analysts, 56.76% of analysts recommend a 'BUY' rating for Amgen Inc. Average target price of $352.03
Amgen Inc Share Price Target
Get share price movements and forecasts by analysts on Amgen Inc.
What analysts predicted
0.76%UPSIDE
Target Price
$352.03
Current Price
$349.36
Analyzed by
37 Analysts
Target
$352.03
Amgen Inc target price $352.03, a slight upside of 0.76% compared to current price of $349.36. According to 37 analysts rating.
Amgen Inc Stock’s Investor Sentiment and Interest
Investment in Amgen Inc Shares on INDmoney has grown by 13.33% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:13.33% versus previous 30 day period
Search interest for Amgen Inc Stock has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Amgen Inc Quarterly Profit & Loss
All numbers in Millions USD
Amgen Inc Annual Profit & Loss
All numbers in Millions USD
Amgen Inc Quarterly Cash Flow
All numbers in Millions USD
Amgen Inc Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own Amgen Inc Stock
Check out the Mutual Funds with significant holdings in Amgen Inc.
Funds | Holdings | Shares Held |
|---|---|---|
 Motilal Oswal S&P 500 Index Fund Direct Growth | 0.33762% | 4021 |
 Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth | 1.45379% | 730 |
 ICICI Prudential NASDAQ 100 Index Fund Direct Growth | 1.07279% | 8933 |
Global Institutional Holdings in Amgen Inc
Amgen Inc News & Key Events
Today's Timeline - 10 April
Fri, 10:14 AM
-Amgen announces positive Phase 3 trial results for subcutaneous TEPEZZA in Thyroid Eye Disease, showing significant efficacy.
Fri, 01:40 PM
-Amgen's lung cancer drug tarlatamab receives approval in China, with potential annual sales exceeding $2 billion.
Insights on Amgen Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Amgen Inc. has shown strong financial performance over the last four quarters, with revenues increasing consistently. The company's revenue has grown from $8.14 billion to $9.89 billion, representing an average increase of 6.2% per quarter.
NO EFFECTAgainst Peers
In the last 3 years, ASTRAZENECA PLC has given 173.3% return, outperforming this stock by 132.9%
- NO EFFECT
Against Peers
In the last 1 year, ASTRAZENECA PLC has given 197.7% return, outperforming this stock by 172.1%
NEGATIVE IMPACTProfit Down
Amgen Inc. has experienced a decline in its net profit over the last two quarters. The net profit dropped from $3.21 billion to $1.33 billion, with an average decrease of 58.6% per quarter.
- NEGATIVE IMPACT
Price Dip
In the last 7 days, AMGN stock has moved down by -0.8%
About Amgen Inc
| Organisation | Amgen Inc |
| Headquarters | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 |
| Industry | Drug Manufacturers - General |
| CEO | Mr. Robert A. Bradway |
| E-voting on shares | Click here to vote |
Key Management of Amgen Inc
Name | Title |
|---|---|
Mr. Murdo Gordon | Executive Vice President of Global Commercial Operations |
Mr. Esteban Santos | Executive Vice President of Operations |
Mr. Matthew C. Busch | Chief Accounting Officer & VP of Finance |
Mr. Howard Y. Chang M.D., Ph.D. | Senior VP of Global Research & Chief Scientific Officer |
Mr. Robert A. Bradway | Chairman & CEO |
Dr. David M. Reese M.D. | Executive VP & CTO |
Dr. James E. Bradner M.D. | Executive Vice President of Research & Development |
Mr. Scott Skellenger | Senior VP & Chief Information Officer |
Casey Capparelli | Executive Director of Investor Relations |
Mr. Peter H. Griffith | Executive VP & CFO |
FAQs
What is Amgen Inc share price today?
Amgen Inc share price today is $349.36 as on at the close of the market. Amgen Inc share today touched a day high of $351.25 and a low of $346.6.
What is the 52 week high and 52 week low for Amgen Inc share?
Amgen Inc share touched a 52 week high of $391.29 on and a 52 week low of $261.43 on . Amgen Inc stock price today i.e. is closed at $349.36,which is 10.72% down from its 52 week high and 33.63% up from its 52 week low.
What is Amgen Inc's market capitalisation today?
Amgen Inc market capitalisation is $0.19T as on .
How to invest in Amgen Inc Stock (AMGN) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Amgen Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Amgen Inc Shares that will get you 0.0043 shares as per Amgen Inc share price of $349.36 per share as on April 17, 2026 at 1:29 am IST.
What is the minimum amount required to buy Amgen Inc Stock (AMGN) from India?
Indian investors can start investing in Amgen Inc (AMGN) shares with as little as ₹93.289 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹932.89 in Amgen Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Amgen Inc share’s latest price of $349.36 as on April 17, 2026 at 1:29 am IST, you will get 0.0286 shares of Amgen Inc. Learn more about
fractional shares .
What are the returns that Amgen Inc has given to Indian investors in the last 5 years?
Amgen Inc stock has given 36.64% share price returns and 25.08% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?